Detalhe da pesquisa
1.
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
N Engl J Med
; 381(17): 1632-1643, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566309
2.
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Blood
; 121(1): 159-69, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100311
3.
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
Blood
; 121(2): 385-91, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23160462
4.
Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 109(17): 6668-73, 2012 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22493267
5.
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808.
Cancer
; 120(7): 1010-7, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24382782
6.
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Blood
; 120(2): 249-58, 2012 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22529287
7.
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.
Blood
; 119(10): 2314-24, 2012 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22251480
8.
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
Blood
; 118(15): 4188-98, 2011 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21828125
9.
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.
Blood
; 118(26): 6920-9, 2011 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22031865
10.
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.
Blood
; 116(9): 1413-21, 2010 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20522709
11.
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(18): 3622-6, 2010 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20656931
12.
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(25): 5660-9, 2010 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20841507
13.
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia.
Blood
; 115(12): 2462-72, 2010 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20075157
14.
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(5): 788-92, 2010 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20442368
15.
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.
Biol Blood Marrow Transplant
; 17(12): 1796-803, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699879
16.
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
N Engl J Med
; 358(18): 1919-28, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18450603
17.
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Haematologica
; 96(10): 1488-95, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21659357
18.
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study.
J Clin Oncol
; 39(4): 273-284, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33503393
19.
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.
Blood
; 112(5): 2013-6, 2008 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18566324
20.
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
Blood
; 112(10): 4193-201, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18716133